White House Issues Warning Over Industrial-Scale AI Intellectual Property Theft
, , , ,

White House Issues Warning Over Industrial-Scale AI Intellectual Property Theft

The United States government has issued a formal warning regarding what it describes as industrial-scale campaigns by Chinese entities to replicate proprietary American artificial intelligence systems. These operations reportedly utilize a process known as “distillation,” where sophisticated, high-cost AI models are leveraged to train smaller, cheaper replicas that are then distributed commercially. By bypassing the […]
OpenAI Launches GPT-5.5: A New Era of Autonomous AI Problem Solving
, , ,

OpenAI Launches GPT-5.5: A New Era of Autonomous AI Problem Solving

OpenAI has officially unveiled its latest artificial intelligence model, GPT-5.5, representing a major milestone in the development of autonomous systems. This iteration is specifically engineered to handle highly complex workflows, including sophisticated software development, intricate coding tasks, and comprehensive research projects. By significantly reducing the requirement for manual human intervention, the model seeks to transform […]
DOJ Inspector General Launches Formal Audit into Epstein Records Transparency
, , ,

DOJ Inspector General Launches Formal Audit into Epstein Records Transparency

The Department of Justice’s Office of the Inspector General (OIG) has officially initiated a comprehensive audit to evaluate how the agency manages and discloses records tied to the late financier Jeffrey Epstein. This oversight initiative is a direct response to mounting concerns regarding the department’s adherence to the Epstein Files Transparency Act, a legislative mandate […]
Federal Policy Shift: Marijuana Reclassification Signals Major Industry Transformation
, , , , ,

Federal Policy Shift: Marijuana Reclassification Signals Major Industry Transformation

The United States federal government is initiating a historic shift in drug policy by moving to reclassify marijuana from a Schedule I substance to a Schedule III category under the Controlled Substances Act. This regulatory adjustment acknowledges the therapeutic potential of cannabis, placing it in a category alongside medications like codeine-based pain relievers, rather than […]